News
Gland Pharma shares gained 3.2 per cent in trade on Tuesday, logging an intraday high at ₹1,800 per share on BSE. The stock ...
Pharmexcil appoints two advisors for streamlining regulatory support for exporters: Shardul Nautiyal, Mumbai Thursday, June 26, 2025, 08:00 Hrs [IST] In a strategic move to bolste ...
Discover why leaders in the pharmaceutical industry are investing in future-ready, smart digital strategies for process ...
Collaboration enables testing of nitrosamine impurities, allowing sponsors to demonstrate acceptable use of rifampin in drug-drug interaction studiesDURHAM, N.C., June 24, 2025 (GLOBE NEWSWIRE) -- ...
The record date for bonus share issue has been notified by the Board of Directors of the pharmaceutical firm listed on the ...
The designation reinforces the potential of QRX003 as a therapeutic candidate for a profoundly underserved pediatric population. It follows earlier regulatory recognition by the European Medicines ...
In fact, there is AI software dedicated specifically to analysing regulatory requirements and helping organisations navigate complex and constantly changing compliance frameworks.
Pfizer's revenue slump is temporary. New launches and Seagen integration drive 2025 growth. Read here for an investment ...
CBD, an innovative injectable liposomal drug product designed for the sustained release of synthetic CBD. Supported by ...
6hOpinion
The Journal News on MSNDonald Trump's potential tariffs on medicines will hurt New Yorkers | OpinionAnd tariffs would increase costs for New York's public health programs. New York's per-capita state Medicaid spending is the ...
(NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results